William Blair Investment Management
TRIB

William Blair Investment Management’s Trinity Biotech TRIB Stock Holding History

William Blair Investment Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,024
Closed -$8.86M – 470
2015
Q4 		$8.86M Buy
5,024
+212
+4% +$375K 0.04% 296
2015
Q3 		$8.26M Buy
+4,812
New +$11.6M 0.02% 731

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

William Blair Investment Management's TRIB Position: Q1 2016 in Review

William Blair Investment Management sold out of Trinity Biotech (TRIB) in Q1 2016, closing a stake of 5,024 shares — an estimated $8.86M sold.

William Blair Investment Management first reported a position in TRIB in Q3 2015 and held it in 2 quarters. The position peaked at $8.86M in Q4 2015. 79 funds tracked by Wall St. Rank hold TRIB as of Q1 2016.

  • William Blair Investment Management reported no remaining Trinity Biotech position as of Q1 2016 after selling out during the quarter.
  • William Blair Investment Management sold 5,024 Trinity Biotech shares in Q1 2016, an estimated $8.86M.
  • William Blair Investment Management first reported a position in Trinity Biotech in Q3 2015 and held it in 2 quarters.
  • William Blair Investment Management's Trinity Biotech position peaked at $8.86M in Q4 2015.
  • 79 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2016.

Based on William Blair Investment Management's 13F filing for Q1 2016, filed 16 May 2016.